185 related articles for article (PubMed ID: 28931757)
1. VISTA.COMP - an engineered checkpoint receptor agonist that potently suppresses T cell-mediated immune responses.
Prodeus A; Abdul-Wahid A; Sparkes A; Fischer NW; Cydzik M; Chiang N; Alwash M; Ferzoco A; Vacaresse N; Julius M; Gorczysnki RM; Gariépy J
JCI Insight; 2017 Sep; 2(18):. PubMed ID: 28931757
[TBL] [Abstract][Full Text] [Related]
2. Immune-checkpoint proteins VISTA and PD-1 nonredundantly regulate murine T-cell responses.
Liu J; Yuan Y; Chen W; Putra J; Suriawinata AA; Schenk AD; Miller HE; Guleria I; Barth RJ; Huang YH; Wang L
Proc Natl Acad Sci U S A; 2015 May; 112(21):6682-7. PubMed ID: 25964334
[TBL] [Abstract][Full Text] [Related]
3. Targeting the V-Type Immunoglobulin Domain-Containing Suppressor to T Cell Activation (VISTA) with Agonist Monoclonal Antibodies in Autoimmunity.
Jung M; Bonavida B
Crit Rev Immunol; 2022; 42(4):37-49. PubMed ID: 37022358
[TBL] [Abstract][Full Text] [Related]
4. The immune checkpoint molecule VISTA regulates allergen-specific Th2-mediated immune responses.
Ohno T; Zhang C; Kondo Y; Kang S; Furusawa E; Tsuchiya K; Miyazaki Y; Azuma M
Int Immunol; 2018 Feb; 30(1):3-11. PubMed ID: 29267882
[TBL] [Abstract][Full Text] [Related]
5. CD71+VISTA+ erythroid cells promote the development and function of regulatory T cells through TGF-β.
Shahbaz S; Bozorgmehr N; Koleva P; Namdar A; Jovel J; Fava RA; Elahi S
PLoS Biol; 2018 Dec; 16(12):e2006649. PubMed ID: 30550561
[TBL] [Abstract][Full Text] [Related]
6. VISTA Is Crucial for Corneal Allograft Survival and Maintenance of Immune Privilege.
Kunishige T; Taniguchi H; Ohno T; Azuma M; Hori J
Invest Ophthalmol Vis Sci; 2019 Dec; 60(15):4958-4965. PubMed ID: 31790558
[TBL] [Abstract][Full Text] [Related]
7. Rationally targeted anti-VISTA antibody that blockades the C-C' loop region can reverse VISTA immune suppression and remodel the immune microenvironment to potently inhibit tumor growth in an Fc independent manner.
Thakkar D; Paliwal S; Dharmadhikari B; Guan S; Liu L; Kar S; Tulsian NK; Gruber JJ; DiMascio L; Paszkiewicz KH; Ingram PJ; D Boyd-Kirkup J
J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35131861
[TBL] [Abstract][Full Text] [Related]
8. Decreased Expression of Negative Immune Checkpoint VISTA by CD4+ T Cells Facilitates T Helper 1, T Helper 17, and T Follicular Helper Lineage Differentiation in GCA.
Hid Cadena R; Reitsema RD; Huitema MG; van Sleen Y; van der Geest KSM; Heeringa P; Boots AMH; Abdulahad WH; Brouwer E
Front Immunol; 2019; 10():1638. PubMed ID: 31379838
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of allogeneic islet graft rejection by VISTA-conjugated liposome.
Guo M; Han S; Liu Y; Guo W; Zhao Y; Liu F; Shi X; Ding G; Wang Q
Biochem Biophys Res Commun; 2019 Aug; 516(3):914-920. PubMed ID: 31272717
[TBL] [Abstract][Full Text] [Related]
10. M351-0056 is a novel low MW compound modulating the actions of the immune-checkpoint protein VISTA.
Hu X; Qie C; Jiang J; Xie X; Chen W; Liu W; Liu J
Br J Pharmacol; 2021 Mar; 178(6):1445-1458. PubMed ID: 33450048
[TBL] [Abstract][Full Text] [Related]
11. An engineered antibody binds a distinct epitope and is a potent inhibitor of murine and human VISTA.
Mehta N; Maddineni S; Kelly RL; Lee RB; Hunter SA; Silberstein JL; Parra Sperberg RA; Miller CL; Rabe A; Labanieh L; Cochran JR
Sci Rep; 2020 Sep; 10(1):15171. PubMed ID: 32938950
[TBL] [Abstract][Full Text] [Related]
12. VISTA: A Target to Manage the Innate Cytokine Storm.
ElTanbouly MA; Zhao Y; Schaafsma E; Burns CM; Mabaera R; Cheng C; Noelle RJ
Front Immunol; 2020; 11():595950. PubMed ID: 33643285
[TBL] [Abstract][Full Text] [Related]
13. VISTA deficiency attenuates antibody-induced arthritis and alters macrophage gene expression in response to simulated immune complexes.
Ceeraz S; Eszterhas SK; Sergent PA; Armstrong DA; Ashare A; Broughton T; Wang L; Pechenick D; Burns CM; Noelle RJ; Vincenti MP; Fava RA
Arthritis Res Ther; 2017 Dec; 19(1):270. PubMed ID: 29216931
[TBL] [Abstract][Full Text] [Related]
14. VISTA Stimulation of VSIG4-Positive Macrophages Strongly Suppresses T Cell Proliferation via Excessive Nitric Oxide Production in Sepsis.
Lee SW
Biol Pharm Bull; 2021 Nov; 44(11):1645-1652. PubMed ID: 34433706
[TBL] [Abstract][Full Text] [Related]
15. Identification of active small-molecule modulators targeting the novel immune checkpoint VISTA.
Li TT; Jiang JW; Qie CX; Xuan CX; Hu XL; Liu WM; Chen WT; Liu J
BMC Immunol; 2021 Aug; 22(1):55. PubMed ID: 34380434
[TBL] [Abstract][Full Text] [Related]
16. VISTA expressed in tumour cells regulates T cell function.
Mulati K; Hamanishi J; Matsumura N; Chamoto K; Mise N; Abiko K; Baba T; Yamaguchi K; Horikawa N; Murakami R; Taki M; Budiman K; Zeng X; Hosoe Y; Azuma M; Konishi I; Mandai M
Br J Cancer; 2019 Jan; 120(1):115-127. PubMed ID: 30382166
[TBL] [Abstract][Full Text] [Related]
17. VISTA is an immune checkpoint molecule for human T cells.
Lines JL; Pantazi E; Mak J; Sempere LF; Wang L; O'Connell S; Ceeraz S; Suriawinata AA; Yan S; Ernstoff MS; Noelle R
Cancer Res; 2014 Apr; 74(7):1924-32. PubMed ID: 24691993
[TBL] [Abstract][Full Text] [Related]
18. Novel Benzimidazoles as Potent Small-Molecule Inhibitors and Degraders of V-Domain Ig Suppressor of T-Cell Activation (VISTA).
Wang T; Wang K; Zhang Y; Zhang K; Cai S; Jiang S; Xiao Y; Zhang X
J Med Chem; 2023 Sep; 66(17):11881-11892. PubMed ID: 37594853
[TBL] [Abstract][Full Text] [Related]
19. VISTA as a ligand downregulates LPS-mediated inflammation in macrophages and neutrophils.
Vivian Ma YH; Sparkes A; Saha S; Gariépy J
Cell Immunol; 2022 Sep; 379():104581. PubMed ID: 35933919
[TBL] [Abstract][Full Text] [Related]
20. VISTA is a checkpoint regulator for naïve T cell quiescence and peripheral tolerance.
ElTanbouly MA; Zhao Y; Nowak E; Li J; Schaafsma E; Le Mercier I; Ceeraz S; Lines JL; Peng C; Carriere C; Huang X; Day M; Koehn B; Lee SW; Silva Morales M; Hogquist KA; Jameson SC; Mueller D; Rothstein J; Blazar BR; Cheng C; Noelle RJ
Science; 2020 Jan; 367(6475):. PubMed ID: 31949051
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
